Termination of Licenses Sample Clauses

Termination of Licenses. Except as necessary for ZIOPHARM to continue to develop and commercialize the Retained Products as permitted by Section 10.4(a), all rights and licenses granted by Intrexon to ZIOPHARM under this Agreement shall terminate and shall revert to Intrexon without further action by either Intrexon or ZIOPHARM. ZIOPHARM’s license with respect to Retained Products shall be exclusive or non-exclusive, as the case may be, on the same terms as set forth in Section 3.1.
Termination of Licenses. Notwithstanding the foregoing, the licenses granted under ARTICLE 3 to the PARTY committing the material breach under Section 5.2, may be canceled immediately by the PARTY terminating the AGREEMENT and such breaching PARTY shall promptly forward to the other PARTY all copies of CONFIDENTIAL INFORMATION, blue prints, drawings and data which it may have in written or graphic or machine readable form and which have been proposed or reproduced by it from the CONFIDENTIAL INFORMATION received from the other PARTY. The termination of this AGREEMENT pursuant to Section 5.2 shall not affect the rights and licenses previously granted to the non-breaching PARTY, which shall continue in full force and effect.
Termination of Licenses. In the event of a termination of this Agreement by COMPANY pursuant to Article 9.2. 9.3 or 9.4 or by SELEXIS pursuant to Article 9.2 or 9.3, all and any rights and licenses granted under this Agreement shall terminate upon termination of this Agreement, except for the licenses which have become perpetual pursuant to Article 3.1.3.
Termination of Licenses. All rights and licenses granted to Artelo hereunder shall terminate.
Termination of Licenses. Upon termination of this Agreement all license grants from Licensor to Licensee shall immediately cease, and Licensee shall immediately cease using, importing, making, having made, offering for sale, and selling Products. Notwithstanding the foregoing, subject to the other provisions of this Agreement (including ARTICLE III), upon termination of this Agreement, Licensee shall have six (6) months in which to fulfill all existing contractual obligations involving or relating to the Products and to sell all inventory existing at the date of termination of this Agreement (the “Post-Termination Sale”). In the event this Agreement terminates because Licensor no longer has a Patent Right on which royalties are due, then Licensee is under no obligation to pay royalties or cease using, importing, making, having made, offering for sale, and selling Products.
Termination of Licenses. Except as expressly provided in this SECTION 12, all rights and licenses granted to Novartis under this Agreement for such Product and the related Trademarks shall immediately terminate; provided, that, subject to Heska's rights under CLAUSE (B) below, Novartis may sell on a nonexclusive basis but otherwise on the terms set forth in this Agreement its remaining inventory of such Product for a period of up to ninety (90) days following the date of termination; and
Termination of Licenses. Terminate, lose, fail to hold or fail to renew, or permit any of its Subsidiaries to terminate, lose, fail to hold or fail to renew, any license, permit or authorization granted by the FCC if such termination, loss or failure to hold or failure to renew would have a materially adverse effect upon the business, condition (financial or otherwise), operations, properties or prospects of the Borrower or any such Subsidiary.
Termination of Licenses. Upon termination of this Agreement:
Termination of Licenses. Except as necessary for Synthetic to continue to obtain regulatory approval for, clinically develop, use, manufacture and Commercialize the Retained Products in the Field as permitted by Section 10.4(a), all rights and licenses granted by Intrexon to Synthetic under this Agreement shall terminate and shall revert to Intrexon without further action by either Intrexon or Synthetic. Synthetic’s license with respect to Retained Products shall be exclusive or non-exclusive, as the case may be, on the same terms as set forth in Section 3.1.
Termination of Licenses. In the event of a termination of this Agreement by COMPANY pursuant to Section 7,2, 7.3, or 7.4 or by Selexis pursuant to Sections 7.2 or 7.3, the rights and licenses granted under this Agreement shall terminate other than those licenses which have become perpetual as described in Sections 3.1,3 and 7.1.